V16 9116 (Viokace 78,300 USP units amylase; 20,880 USP units lipase; 78,300 USP units protease)

Generic Name: pancrelipase

Pill imprint V16 9116 has been identified as Viokace 78,300 USP units amylase; 20,880 USP units lipase; 78,300 USP units protease.

Viokace is used in the treatment of chronic pancreatitis; pancreatic exocrine dysfunction; cystic fibrosis and belongs to the drug class digestive enzymes. Risk cannot be ruled out during pregnancy. Viokace 78,300 USP units amylase; 20,880 USP units lipase; 78,300 USP units protease is not a controlled substance under the Controlled Substance Act (CSA).

Viokace

Generic Name:

pancrelipase

Imprint:

V16 9116

Strength:

78,300 USP units amylase; 20,880 USP units lipase; 78,300 USP units protease

Color:

Tan

Shape:

Elliptical / Oval

Availability:

Rx and/or OTC

Drug Class:

Digestive enzymes

Pregnancy Category:

C - Risk cannot be ruled out

CSA Schedule:

Not a controlled drug

Manufacturer:

Aptalis Pharma US, Inc.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.